Florham Park, New Jersey — February 15, 2017 — BASF has launched a new fundraising promotion in partnership with Driven to Cure (DTC), a charity with the goal of raising awareness and additional research funding for rare kidney cancers. The new promotion is called Paint with a Purpose.
Andrew Lee is the President and CEO of DTC. He was diagnosed with a rare form of kidney cancer, HLRCC, in 2015 at the age of 19. With the help of his father, Bruce, Andrew is living his dream as the owner of a 2015 Nissan GT-R, which they rebuilt and painted orange, the colour representing kidney cancer. The colour is a unique mix of BASF Glasurit basecoats, now named Glasurit DTC Orange.
BASF presented Andrew and Bruce a cheque for $10,000 at the company’s automotive refinish team meeting earlier this month. Immediately following the cheque presentation, BASF announced the Paint with a Purpose promotion.
Glasurit DTC Orange is now available to order through BASF. All proceeds of the paint sales will be donated to DTC. After painting cars with the unique mix, builders are asked to send photos to refinish_comm@basf.com to be posted on BASF social media.
“Driven to Cure’s mission is to raise awareness about rare kidney cancers like HLRCC. With our new amazing Glasurit orange colour on the Driven to Cure Nissan GT-R, which is the colour for kidney cancer, we are doing just that,” said Andrew. “When starting Driven to Cure, I never thought we would have a relationship like this with such a great company. We are so proud of the BASF team for supporting Driven to Cure and for joining forces with many in the car community who already support us. We are all Driven to Cure!”
Since building the GT-R, Andrew has been traveling to car shows spreading the word and raising funds. To date more than $200,000 has been raised.
For more information on DTC, please visit driventocure.org.
 |
|
| Andrew Lee’s Nissan GT-R, painted in Glasurit DTC Orange. |
